Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2025-08-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
半年度非经营性资金占用及其他关联资金往来情况汇总表
Regulatory Filings Classification · 90% confidence The document is a summary table detailing non-operating fund occupation and other related party fund transactions for the first half of 2025. It includes financial figures such as balances and transaction amounts, but it is a specific financial summary related to related-party transactions rather than a full financial report. The document length is short (1245 characters), and it appears to be a regulatory disclosure or compliance-related summary rather than a comprehensive report like an Interim Report (IR) or Annual Report (10-K). It does not fit the definitions of other categories such as Audit Report, Earnings Release, or Management Reports. Given the nature and length, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not neatly fit into other categories.
2025-08-29 Chinese
2025年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "2025 年半年度报告摘要" which translates to "2025 Semi-Annual Report Summary." It contains detailed financial data such as revenue, net profit, earnings per share, and net asset values for the half-year period. It also includes extensive operational and business updates, technology development, market expansion, and strategic cooperation information. The presence of comprehensive financial metrics and business analysis for a half-year period clearly indicates this is an Interim / Quarterly Report. The document length (6903 characters) and content depth confirm it is the report itself, not just an announcement or summary notice. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2025
2025-08-29 Chinese
关于全资子公司基因测序仪获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (1284 characters) from a company about its wholly owned subsidiary obtaining a medical device registration certificate from the National Medical Products Administration (NMPA). It details the product name, registration number, specifications, and the impact on the company. There are no financial statements, no detailed financial data, no earnings or management discussion, and no mention of shareholder votes or meetings. The document is an official announcement about a regulatory approval related to a product, not a financial report or meeting material. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into other specific categories like Annual Report, Earnings Release, or Capital Update.
2025-08-26 Chinese
关于为全资子公司提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the provision of a guarantee by the parent company for its wholly-owned subsidiary's bank credit. It includes details about the guarantee, the subsidiary's financial data, board approval, and compliance with regulatory requirements. The document is relatively short (2150 characters) and focuses on a specific corporate action related to financing support rather than presenting comprehensive financial statements or audit results. It does not contain full financial reports or earnings data but rather a disclosure of a guarantee arrangement. This fits the category of Capital/Financing Update (CAP), which covers updates on company financing activities or capital structure changes such as guarantees for loans.
2025-08-20 Chinese
第十届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 16th meeting of the 10th Board of Directors of the company. It details the meeting date, attendance, and the approval of a guarantee for a subsidiary's loan. There is no financial report or detailed financial data presented. The document is an announcement of board decisions, specifically about providing a guarantee for a subsidiary's financing. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document is short and does not contain financial statements or detailed analysis, so it is not an Annual Report or Interim Report. It is not a Regulatory Filing or Report Publication Announcement because it contains substantive information about board resolutions, not just a notice or certification. Therefore, the correct classification is MANG with high confidence.
2025-08-20 Chinese
关于控股股东之一致行动人所持公司股份将被司法拍卖的进展公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the judicial auction of shares held by a controlling shareholder's concert party. It details the number of shares being auctioned, the legal basis for the auction, the auction process, and the potential impact on the company. There are no financial statements, management discussion, or detailed financial data. The document is an update on a legal and shareholder-related event, specifically a judicial auction of shares, which is a regulatory announcement about shareholding status and legal proceedings. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a full legal proceeding report but an announcement related to legal action affecting shareholding. Given the nature and content, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-08-13 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.